Not many reproductive-aged women have had their lipid levels checked, with more than three-quarters of those attending a postpartum visit not having undergone lipid screening. This underscores peripartum period as an important window of opportunity for screening, according to a study presented at the American College of Cardiology Annual Scientific Session 2019.
High-intensity interval training (HIIT) is better than moderate-intensity continuous training at cutting abdominal fat distribution and total body fat and at increasing lean mass, according to a new study presented at the recently concluded American College of Cardiology's 68th Annual Scientific Session.
Long-term results of the POET* trial have suggested that patients with left-sided infective endocarditis (IE) could safely switch from conventional intravenous (IV) antibiotics to oral antibiotics, with oral antibiotics associated with a reduced mortality risk.
Extensive coronary artery calcium (CAC ≥1,000) in patients corresponds to a very high-risk phenotype that is associated with mortality outcomes equal to high-risk patients treated for secondary prevention of cardiovascular disease (CVD), reports a study presented at the American College of Cardiology (ACC) Annual Scientific Sessions 2019.
Following a low-carbohydrate diet to shed excess pounds may be bad for the heart, such that individuals consuming low levels of carbohydrates are at increased risk of developing atrial fibrillation, according to a study presented at the American College of Cardiology Annual Scientific Session 2019.
Icosapent ethyl – a prescription and highly purified version of the omega-3 fatty acid, eicosapentaenoic acid (EPA) – takes the spotlight in REDUCE-IT* as it markedly reduced the rate of first and ischaemic events in individuals with high cardiovascular (CV) risk**.
In intravenous drug users, hospital admissions for infective endocarditis (IE) appear to be on the rise, with the prevailing treatment approach shifting away from surgical to medical, according to a new study presented at the recently concluded 68th Annual Scientific Session & Expo of the American College of Cardiology (ACC 2019).
A smartwatch algorithm may help detect irregular heart rate – via a pulse notification – indicating possible atrial fibrillation (AF), according to preliminary results of the Apple Heart Study* presented at ACC.19.
Several strategies have been proposed to help manage the adverse events (AEs) that emerged during the BEACON CRC trial which assessed the effect of encorafenib plus cetuximab in patients with BRAF V600E mutant metastatic colorectal cancer (mCRC) who had progressed after one or two prior regimens.